NO20003868L - Hydroksam- og karboksylsyrederivater - Google Patents
Hydroksam- og karboksylsyrederivaterInfo
- Publication number
- NO20003868L NO20003868L NO20003868A NO20003868A NO20003868L NO 20003868 L NO20003868 L NO 20003868L NO 20003868 A NO20003868 A NO 20003868A NO 20003868 A NO20003868 A NO 20003868A NO 20003868 L NO20003868 L NO 20003868L
- Authority
- NO
- Norway
- Prior art keywords
- hydroxamic
- carboxylic acid
- acid derivatives
- receptors
- tnf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9802073.8A GB9802073D0 (en) | 1998-01-30 | 1998-01-30 | Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
GBGB9819574.6A GB9819574D0 (en) | 1998-09-08 | 1998-09-08 | Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
US09/239,603 US6100266A (en) | 1998-01-30 | 1999-01-29 | Hydroxamic and carboxylic acid derivatives |
PCT/GB1999/000313 WO1999038843A1 (en) | 1998-01-30 | 1999-01-29 | Hydroxamic and carboxylic acid derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20003868D0 NO20003868D0 (no) | 2000-07-28 |
NO20003868L true NO20003868L (no) | 2000-07-28 |
NO326266B1 NO326266B1 (no) | 2008-10-27 |
Family
ID=27269200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003868A NO326266B1 (no) | 1998-01-30 | 2000-07-28 | Hydroksam- og karboksylsyrederivater, farmasoytiske preparater inneholdende slike for anvendelse i terapi samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling eller forebygging av sykdommer |
Country Status (18)
Country | Link |
---|---|
US (1) | US6100266A (no) |
EP (1) | EP1051395B1 (no) |
JP (1) | JP2002501943A (no) |
CN (1) | CN100402496C (no) |
AT (1) | ATE346041T1 (no) |
AU (1) | AU735929B2 (no) |
BR (1) | BR9908215A (no) |
CA (1) | CA2317455C (no) |
CY (1) | CY1106338T1 (no) |
DE (1) | DE69934094T2 (no) |
DK (1) | DK1051395T3 (no) |
ES (1) | ES2277424T3 (no) |
HK (1) | HK1029330A1 (no) |
HU (1) | HUP0100597A3 (no) |
IL (1) | IL137146A0 (no) |
NO (1) | NO326266B1 (no) |
PL (1) | PL200418B1 (no) |
WO (1) | WO1999038843A1 (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9919776D0 (en) * | 1998-08-31 | 1999-10-27 | Zeneca Ltd | Compoujnds |
US20040122011A1 (en) * | 1998-12-23 | 2004-06-24 | Pharmacia Corporation | Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy |
CA2374460A1 (en) | 1999-06-04 | 2000-12-14 | Astrazeneca Ab | Inhibitors of metalloproteinases |
JP2003519119A (ja) * | 1999-12-24 | 2003-06-17 | スミスクライン ビーチャム パブリック リミテッド カンパニー | (ヘテロ)ビシクリルメタンスルホニルアミノ置換ヒドロキサム酸誘導体 |
JP4256095B2 (ja) * | 2000-02-21 | 2009-04-22 | アストラゼネカ・アクチエボラーグ | メタロプロテイナーゼの阻害剤としてのピペリジン−およびピペラジン置換n−ヒドロキシホルムアミド類 |
WO2001062750A1 (en) * | 2000-02-21 | 2001-08-30 | Astrazeneca Ab | Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
IL152990A0 (en) * | 2000-05-25 | 2003-06-24 | Smithkline Beecham Plc | Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides |
FR2827859B1 (fr) * | 2001-07-30 | 2005-09-23 | Lipha | Derives 4-(arylthio) - ou 4-(heteroarylthio) -butyrique dans la preparation de medicaments destines au traitement du diabete |
GB0119474D0 (en) * | 2001-08-09 | 2001-10-03 | Astrazeneca Ab | Compounds |
GB0119473D0 (en) * | 2001-08-09 | 2001-10-03 | Astrazeneca | Compounds |
GB0119472D0 (en) * | 2001-08-09 | 2001-10-03 | Astrazeneca Ab | Compounds |
ES2319970T3 (es) | 2001-09-07 | 2009-05-18 | Kaken Pharmaceutical Co., Ltd. | Derivados de acido hidroxamico inverso. |
GB0128376D0 (en) * | 2001-11-27 | 2002-01-16 | Smithkline Beecham Plc | Novel compounds |
GB0128378D0 (en) * | 2001-11-27 | 2002-01-16 | Smithkline Beecham Plc | Novel Compounds |
SE0301922D0 (sv) | 2003-06-27 | 2003-06-27 | Astrazeneca Ab | Novel compounds |
WO2007060132A1 (en) * | 2005-11-24 | 2007-05-31 | Laboratoires Serono S.A. | N-hydroxyamide derivatives and use thereof |
US20100226922A1 (en) * | 2006-06-08 | 2010-09-09 | Dorothea Maetzel | Specific protease inhibitors and their use in cancer therapy |
US8765814B2 (en) * | 2010-07-08 | 2014-07-01 | Kaken Pharmaceutical Co., Ltd. | N-hydroxyformamide derivative and medicament containing same |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4267293A (en) * | 1992-05-01 | 1993-11-29 | British Biotech Pharmaceuticals Limited | Use of MMP inhibitors |
EP0826000B1 (en) * | 1995-05-10 | 2002-10-23 | Darwin Discovery Limited | Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses |
EP0994104A4 (en) * | 1996-06-27 | 2001-09-12 | Ono Pharmaceutical Co | ARYL SULFIDE, SULFOXIDE AND SULPHONE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM AS AN ACTIVE INGREDIENT |
UA48262C2 (uk) * | 1996-09-27 | 2002-08-15 | Фармація Енд Апджон Компані | <font face="Symbol">b</font>-СУЛЬФОНІЛ ГІДРОКСАМОВІ КИСЛОТИ ЯК ІНГІБІТОРИ МАТРИЧНИХ МЕТАЛОПРОТЕЇНАЗ, ПРОМІЖНА СПОЛУКА ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ |
US5962481A (en) * | 1996-10-16 | 1999-10-05 | American Cyanamid Company | Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
US6476027B1 (en) * | 1997-03-04 | 2002-11-05 | Monsanto Company | N-hydroxy 4-sulfonyl butanamide compounds |
US5985900A (en) * | 1997-04-01 | 1999-11-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
CN1178906C (zh) * | 1997-07-31 | 2004-12-08 | 艾博特公司 | 基质金属蛋白酶的逆异羟肟酸盐抑制剂 |
-
1999
- 1999-01-29 CA CA2317455A patent/CA2317455C/en not_active Expired - Fee Related
- 1999-01-29 AU AU22914/99A patent/AU735929B2/en not_active Ceased
- 1999-01-29 AT AT99902703T patent/ATE346041T1/de active
- 1999-01-29 DE DE69934094T patent/DE69934094T2/de not_active Expired - Lifetime
- 1999-01-29 US US09/239,603 patent/US6100266A/en not_active Expired - Fee Related
- 1999-01-29 CN CNB998024937A patent/CN100402496C/zh not_active Expired - Fee Related
- 1999-01-29 HU HU0100597A patent/HUP0100597A3/hu unknown
- 1999-01-29 EP EP99902703A patent/EP1051395B1/en not_active Expired - Lifetime
- 1999-01-29 DK DK99902703T patent/DK1051395T3/da active
- 1999-01-29 PL PL342184A patent/PL200418B1/pl not_active IP Right Cessation
- 1999-01-29 BR BR9908215-2A patent/BR9908215A/pt not_active Application Discontinuation
- 1999-01-29 WO PCT/GB1999/000313 patent/WO1999038843A1/en active IP Right Grant
- 1999-01-29 JP JP2000530080A patent/JP2002501943A/ja active Pending
- 1999-01-29 ES ES99902703T patent/ES2277424T3/es not_active Expired - Lifetime
- 1999-01-29 IL IL13714699A patent/IL137146A0/xx active IP Right Grant
-
2000
- 2000-07-28 NO NO20003868A patent/NO326266B1/no not_active IP Right Cessation
- 2000-12-14 HK HK00108043A patent/HK1029330A1/xx not_active IP Right Cessation
-
2007
- 2007-02-22 CY CY20071100255T patent/CY1106338T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO326266B1 (no) | 2008-10-27 |
CY1106338T1 (el) | 2011-10-12 |
CA2317455A1 (en) | 1999-08-05 |
BR9908215A (pt) | 2000-11-28 |
AU2291499A (en) | 1999-08-16 |
ES2277424T3 (es) | 2007-07-01 |
NO20003868D0 (no) | 2000-07-28 |
DE69934094D1 (de) | 2007-01-04 |
CN100402496C (zh) | 2008-07-16 |
CA2317455C (en) | 2011-01-25 |
IL137146A0 (en) | 2001-07-24 |
CN1289322A (zh) | 2001-03-28 |
ATE346041T1 (de) | 2006-12-15 |
WO1999038843A1 (en) | 1999-08-05 |
EP1051395A1 (en) | 2000-11-15 |
HUP0100597A3 (en) | 2001-12-28 |
PL200418B1 (pl) | 2009-01-30 |
JP2002501943A (ja) | 2002-01-22 |
HUP0100597A2 (hu) | 2001-08-28 |
DK1051395T3 (da) | 2007-04-02 |
PL342184A1 (en) | 2001-05-21 |
DE69934094T2 (de) | 2007-06-06 |
US6100266A (en) | 2000-08-08 |
AU735929B2 (en) | 2001-07-19 |
HK1029330A1 (en) | 2001-03-30 |
EP1051395B1 (en) | 2006-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20003868D0 (no) | Hydroksam- og karboksylsyrederivater | |
FI971412A (fi) | Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä | |
CY1107495T1 (el) | Χρηση παραγωγων τετρακυκλινης για να αυξανεται παραγωγη ιντepλευκινης-10 | |
CY1109328T1 (el) | Ενωσεις θειενοδιβενζοαζουλενιου ως αναστολεις παραγοντα νεκρωσης ογκου | |
FI961976A (fi) | Peptidyyliyhdisteitä ja niiden terapeuttinen käyttö metalloproteinaasien inhibiittoreina | |
EA200101166A1 (ru) | Ингибиторы металлопротеаз | |
UY26981A1 (es) | Inhibidores de metaloproteinasa del tipo pirimidin-2,4,6-triona | |
NO20002440D0 (no) | Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet | |
BR0308787A (pt) | Inibidores de metaloproteinase de n-substituìdos-heteroarilóxi-aril-espiro-pirimidina- 2,4,6-triona | |
MXPA02011376A (es) | Benzofenonas como inhibidores de il-1beta y tnf-alfa. | |
EA200100315A1 (ru) | Простые тетрагидропиридовые эфиры | |
EA200500849A1 (ru) | Новые соединения лапахона и способы их применения | |
NO20000784L (no) | Nye aggrecanaseinhibitorer og matriksmetalloproteinaser for behandling av artritt | |
BR0314212A (pt) | Projeto de análogos de quimiocina para o tratamento de doenças humanas | |
ATE477236T1 (de) | Alpha-aminosäurederivate mit entzündungshemmender wirkung | |
DK1242410T3 (da) | Nye forbindelser | |
ATE247650T1 (de) | Hydroxamsäure- und carbonsäurederivative | |
ATE394117T1 (de) | Verwendung von cc-chemokine ccl5/rantes mutanten zur behandlung von lebererkrankungen | |
IT1294932B1 (it) | Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie | |
PT1358182E (pt) | Derivados de diazocinas e sua utilizacao como inibidores de triptase | |
SU1549026A1 (ru) | 4-Карбэтокси-4-(2-п-толиламинотиазолил-4)-гексановая кислота, проявляющая противовоспалительную активность |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |